FREMONT, Calif., June 28 /PRNewswire/ -- MicroFluidic Systems (MFSI), a privately-held company, announced today that they have relocated from about 8,000 sqft in Pleasanton, CA to 47790 Westinghouse Dr., Fremont, CA. The new facility is over 18,200 sqft total with 5 biological R and D laboratories including biosafety level 2 (BSL2) capabilities. The facility also has nearly 10,000 sqft of engineering laboratories and manufacturing space. The new facility will be the center for MFSI’s continuing development of its air-borne pathogen detection systems for the Department of Homeland Security’s Advanced Research Projects Agency (HSARPA)
“The move to the new facility represents the significant growth that MFSI is experiencing with its large new contracts from HSARPA,” commented Dr. M. Allen Northrup, MFSI President and CEO. “We now have all the capabilities to produce the prototype systems for autonomous biological agent detection, and move toward the commercialization of these technologies,” he added.
MicroFluidic Systems Inc. (MFSI) was founded in 2001 and is focused on the development of microfluidic systems for automated preparation of biological assays. MFSI personnel have been involved with the development of automated DNA-based pathogen detection systems and microfluidics for the US Government and commercial markets for over 12 years, including the world’s first miniaturized, portable, battery-operated, real-time, polymerase-chain-reaction (PCR)-based detection system. For more information, please contact MFSI at 510-354-0400 or visit the website, www.mfsi.biz.
Statements in this press release are forward-looking. Actual results might differ from these statements due to unforeseen events and uncertainties. MFSI disclaims any intention to or obligation to update these forward-looking statements.
MicroFluidic Systems Inc.
CONTACT: MicroFluidic Systems Inc., +1-510-354-0400
Web site: http://www.mfsi.biz//
